These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7921758)

  • 1. Treatment of systemic vasculitis with cyclophosphamide and steroids: daily oral low-dose cyclophosphamide administration after failure of a pulse intravenous high-dose regimen in four patients.
    Généreau T; Lortholary O; Leclerq P; Grenet D; Tubéry M; Sicard D; Caubarrère I; Guillevin L
    Br J Rheumatol; 1994 Oct; 33(10):959-62. PubMed ID: 7921758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients.
    Guillevin L; Lhote F; Cohen P; Jarrousse B; Lortholary O; Généreau T; Léon A; Bussel A
    Arthritis Rheum; 1995 Nov; 38(11):1638-45. PubMed ID: 7488285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides.
    Gayraud M; Guillevin L; Cohen P; Lhote F; Cacoub P; Deblois P; Godeau B; Ruel M; Vidal E; Piontud M; Ducroix JP; Lassoued S; Christoforov B; Babinet P
    Br J Rheumatol; 1997 Dec; 36(12):1290-7. PubMed ID: 9448590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When should immunosuppressants be prescribed to treat systemic vasculitides?
    Guillevin L; Pagnoux C
    Intern Med; 2003 Apr; 42(4):313-7. PubMed ID: 12729318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide.
    Martin-Suarez I; D'Cruz D; Mansoor M; Fernandes AP; Khamashta MA; Hughes GR
    Ann Rheum Dis; 1997 Aug; 56(8):481-7. PubMed ID: 9306871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylprednisolone in the treatment of Wegener's granulomatosis, polyarteritis nodosa and Churg-Strauss angiitis.
    Guillevin L; Rosser J; Cacoub P; Mousson C; Jarrousee B
    APMIS Suppl; 1990; 19():52-3. PubMed ID: 1981008
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of polyarteritis nodosa and Churg-Strauss syndrome. A meta-analysis of 3 prospective controlled trials including 182 patients over 12 years.
    Guillevin L; Lhote F; Jarrousse B; Fain O
    Ann Med Interne (Paris); 1992; 143(6):405-16. PubMed ID: 1363508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulse cyclophosphamide therapy in Wegener's granulomatosis: a pilot study.
    Drosos AA; Sakkas LI; Goussia A; Siamopoulos KC; Moutsopoulos HM
    J Intern Med; 1992 Sep; 232(3):279-82. PubMed ID: 1402626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic necrotizing vasculitides in Turkey: a comparative analysis of 40 consecutive patients.
    Kamali S; Inanc M; Gul A; Ocal L; Polat NG; Kilicaslan I; Aral O; Konice M
    Rheumatol Int; 2005 Nov; 26(1):16-20. PubMed ID: 15372200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.
    Guillevin L; Cordier JF; Lhote F; Cohen P; Jarrousse B; Royer I; Lesavre P; Jacquot C; Bindi P; Bielefeld P; Desson JF; Détrée F; Dubois A; Hachulla E; Hoen B; Jacomy D; Seigneuric C; Lauque D; Stern M; Longy-Boursier M
    Arthritis Rheum; 1997 Dec; 40(12):2187-98. PubMed ID: 9416856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.
    Gayraud M; Guillevin L; le Toumelin P; Cohen P; Lhote F; Casassus P; Jarrousse B;
    Arthritis Rheum; 2001 Mar; 44(3):666-75. PubMed ID: 11263782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide.
    Hoffman GS; Leavitt RY; Fleisher TA; Minor JR; Fauci AS
    Am J Med; 1990 Oct; 89(4):403-10. PubMed ID: 2220874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide.
    Benenson E; Fries JW; Heilig B; Pollok M; Rubbert A
    Clin Rheumatol; 2005 Jun; 24(3):251-7. PubMed ID: 15940558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in the treatment of Wegener's granulomatosis, polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome.
    Langford CA; Sneller MC
    Curr Opin Rheumatol; 1997 Jan; 9(1):26-30. PubMed ID: 9110130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients.
    Boki KA; Dafni U; Karpouzas GA; Papasteriades C; Drosos AA; Moutsopoulos HM
    Br J Rheumatol; 1997 Oct; 36(10):1059-66. PubMed ID: 9374922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of polyarteritis nodosa and Churg-Strauss syndrome: indications of plasma exchanges.
    Guillevin L; Lhote F
    Transfus Sci; 1994 Dec; 15(4):371-88. PubMed ID: 10155556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of infections in severe necrotising vasculitis patients treated with cyclophosphamide induction therapy: a meta-analysis.
    Jung M; Barra L
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):129-134. PubMed ID: 29799394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades.
    Sharma A; Gopalakrishan D; Nada R; Kumar S; Dogra S; Aggarwal MM; Gupta R; Minz RW; Kakkar N; Vashishtha RK; Singh S
    Int J Rheum Dis; 2014 Jun; 17(5):562-72. PubMed ID: 24237487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.
    Guillevin L; Lhote F; Gayraud M; Cohen P; Jarrousse B; Lortholary O; Thibult N; Casassus P
    Medicine (Baltimore); 1996 Jan; 75(1):17-28. PubMed ID: 8569467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.